David R Epstein
Director at AgomAb Therapeutics NV (AGMB); Director at Tempus AI, Inc. (TEM)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$5K
Total bought / sold$131K / $132K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 9 NewSEC | AGMBAgomAb Therapeutics NV | Buy | 5,00015,000 held (+50%) | $8.90 | $44K | +2.0% |
| Oct 7SEC | AGMBAgomAb Therapeutics NV | Buy | 5,000new position | $8.57 | $43K | +6.0% |
| Oct 7SEC | AGMBAgomAb Therapeutics NV | Buy | 5,00010,000 held (+100%) | $8.70 | $44K | +4.4% |
| Sep 3SEC | TEMTempus AI, Inc. | Sell Plan | 25030,844 held (−1%) | $65.55 | $16K | +8.2% |
| Aug 5SEC | TEMTempus AI, Inc. | Sell Plan | 37031,094 held (−1%) | $43.40 | $16K | +63.4% |
| Jun 3SEC | TEMTempus AI, Inc. | Sell Plan | 25031,464 held (−1%) | $49.40 | $12K | +43.6% |
| Mar 4SEC | TEMTempus AI, Inc. | Sell Plan | 25025,801 held (−1%) | $50.69 | $13K | +39.9% |
| Feb 4SEC | TEMTempus AI, Inc. | Sell Plan | 37026,051 held (−1%) | $59.41 | $22K | +19.4% |
| Dec 3SEC | TEMTempus AI, Inc. | Sell Plan | 25026,421 held (−1%) | $75.55 | $19K | -6.1% |
| Nov 5SEC | TEMTempus AI, Inc. | Sell Plan | 37026,671 held (−1%) | $90.00 | $33K | -21.2% |
- Buy
Director David R Epstein bought $44K of AGMB at $8.90 — raises the stake by 50%.
- Buy
Director David R Epstein bought $43K of AGMB at $8.57 — first open-market purchase in our records; opens a new position.
- Buy
Director David R Epstein bought $44K of AGMB at $8.70 — raises the stake by 100%.
- Sell
Director David R Epstein sold $16K of TEM at $65.55 — pre-scheduled 10b5-1 plan sale.
- Sell
Director David R Epstein sold $16K of TEM at $43.40 — pre-scheduled 10b5-1 plan sale.
- Sell
Director David R Epstein sold $12K of TEM at $49.40 — pre-scheduled 10b5-1 plan sale.